General mgmt

By rray, 15 March, 2023
Exclude Patient Type Detail Header
No
Footnote
<b>NIH 2023.</b> COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Last update 3/6/23. <a href=https://www.covid19treatmentguidelines.nih.gov/><u>Accessed 3/14/23</u></a>
<br><br>
<sup>1</sup> Equivalent daily glucocorticoid dose may be substituted if dexamethasone unavailable.
<br><br>
<sup>2</sup> If baricitinib not available or feasible to use, may use tofacitinib as an alternative. Tofacitinib dose for children hasn’t been established; consult specialist.
Detail Type
Text
Detail Text
Minimize risk of SARS CoV 2 transmission
Anticoagulation Use prophylactic anticoagulation unless contraindicated
Note Activity of anti SARS CoV 2 specific monoclonal antibodies against currently circulating variants is significantly reduced tx w these agents is NOT recommended
Patient Type Detail Header (Long)
General mgmt